Literature DB >> 11982301

Neurologic aspects of Lyme disease.

P K Coyle1, S E Schutzer.   

Abstract

Lyme disease has emerged as a major infection with frequent neurologic manifestations. These manifestations probably reflect several predominantly indirect pathogenetic mechanisms and involve host, vector, and organism factors. With early diagnosis and appropriate antibiotic treatment, patients do well. Because culture is not reliable, diagnosis has relied on positive serology to document exposure. Serology should improve as second-generation assays become available. Although there is a preventive vaccine based on the lipoprotein OspA, newer vaccines in development may prove more desirable. Lyme disease provides a valuable model to study how infectious pathogens cause neurologic disease.

Entities:  

Mesh:

Year:  2002        PMID: 11982301     DOI: 10.1016/s0025-7125(03)00086-5

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  13 in total

1.  Construction and analysis of variants of a polyvalent Lyme disease vaccine: approaches for improving the immune response to chimeric vaccinogens.

Authors:  Christopher G Earnhart; Richard T Marconi
Journal:  Vaccine       Date:  2007-01-17       Impact factor: 3.641

2.  Cerebrospinal fluid-infiltrating CD4+ T cells recognize Borrelia burgdorferi lysine-enriched protein domains and central nervous system autoantigens in early lyme encephalitis.

Authors:  Jan D Lünemann; Harald Gelderblom; Mireia Sospedra; Jacqueline A Quandt; Clemencia Pinilla; Adriana Marques; Roland Martin
Journal:  Infect Immun       Date:  2006-10-23       Impact factor: 3.441

3.  Genotypic variation and mixtures of Lyme Borrelia in Ixodes ticks from North America and Europe.

Authors:  Chris D Crowder; Heather E Matthews; Steven Schutzer; Megan A Rounds; Benjamin J Luft; Oliver Nolte; Scott R Campbell; Curtis A Phillipson; Feng Li; Ranga Sampath; David J Ecker; Mark W Eshoo
Journal:  PLoS One       Date:  2010-05-14       Impact factor: 3.240

4.  A case of Lyme neuroborreliosis with bilateral recurrent laryngeal nerve palsy.

Authors:  M Furtner; M Patjas; B Frauscher; E Schmutzhard; J Willeit
Journal:  JRSM Short Rep       Date:  2010-11-25

5.  Preferential presence of decorin-binding protein B (BBA25) and BBA50 antibodies in cerebrospinal fluid of patients with neurologic Lyme disease.

Authors:  Erol Fikrig; Patricia K Coyle; Steven E Schutzer; Manchuan Chen; Zhidian Deng; Richard A Flavell
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

Review 6.  [Neuroborreliosis].

Authors:  R Kaiser; V Fingerle
Journal:  Nervenarzt       Date:  2009-10       Impact factor: 1.214

7.  Outer surface protein C peptide derived from Borrelia burgdorferi sensu stricto as a target for serodiagnosis of early lyme disease.

Authors:  Paul M Arnaboldi; Rudra Seedarnee; Mariya Sambir; Steven M Callister; Josephine A Imparato; Raymond J Dattwyler
Journal:  Clin Vaccine Immunol       Date:  2013-01-30

8.  Validation of cultivation and PCR methods for diagnosis of Lyme neuroborreliosis.

Authors:  Tjasa Cerar; Katarina Ogrinc; Joze Cimperman; Stanka Lotric-Furlan; Franc Strle; Eva Ruzić-Sabljić
Journal:  J Clin Microbiol       Date:  2008-08-20       Impact factor: 5.948

9.  Identification of OppA2 linear epitopes as serodiagnostic markers for Lyme disease.

Authors:  Giacomo Signorino; Paul M Arnaboldi; Mary M Petzke; Raymond J Dattwyler
Journal:  Clin Vaccine Immunol       Date:  2014-03-12

10.  Lyme disease: clinical diagnosis and treatment.

Authors:  T F Hatchette; I Davis; B L Johnston
Journal:  Can Commun Dis Rep       Date:  2014-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.